Board Composition

Mr. Leonardo Scapozza is appointed as new member of the Board of Adoram Therapeutics SA.

Board Composition

Mr. Hesham Hamed is appointed as new Chairman of Adoram Therapeutics SA.

Incorporation

Adoram Therapeutics SA is registered in the Commercial Register of the canton of Geneva with a share capital of CHF 100,000.00 which is fully paid-in, divided into 10,000,000 common registered shares …

Modification of the board composition

Mr. Clément Javerzac is no longer a member of the board of directors.

Capital increase

New capital increase: CHF 175,012.10, paid up to CHF 125,012.10, divided into 1,000,000 registered shares of CHF 0.10, 290,600 registered shares of CHF 0.10, preferential in terms of liquidation proce…

Board Composition

Mr. David Pejoski is appointed as new member of the Board of Adoram Therapeutics SA.

Capital increase

New capital : CHF 138,743.68. New paid-up share capital: CHF 138,743.68, divided into 13,874,368 registered shares of CHF 0.01 each, with transfer restrictions in accordance with the articles of assoc…

New person

Mr. Stéphane Eimer is appointed as a new member of the board of directors.

Capital increase

New fully paid-up share capital: CHF 100,000 divided into 100,000 registered shares of CHF 1, with transfer restrictions as per the Articles of Association. Ordinary capital increase, in cash and by o…